目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Test
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Test outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Blood Cancer Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of blood cancer
3.2.1.2. Increasing R&D and clinical trials
3.2.1.3. Advancements in diagnostics technologies
3.2.1.4. Rising government initiatives and regulatory support
3.2.2. Market restraint analysis
3.2.2.1. High development cost and accessibility barriers
3.3. Blood Cancer Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis

Chapter 4. Blood Cancer Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Blood Cancer Diagnostics Market: Product Movement Analysis
4.3. Blood Cancer Diagnostics Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
4.4. Instruments
4.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Assay Kits and Reagents
4.5.1. Assay Kits and Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Blood Cancer Diagnostics Market: Test Estimates & Trend Analysis
5.1. Test Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Blood Cancer Diagnostics Market by Test Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Blood Tests
5.5.1. Blood Tests Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Imaging Tests
5.6.1. Imaging Tests Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Biopsy
5.7.1. Biopsy Market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Molecular Test
5.8.1. Molecular Tests Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Blood Cancer Diagnostics Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Blood Cancer Diagnostics Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals and Clinics
6.5.1. Hospitals and Clinics Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Diagnostic Labs
6.6.1. Diagnostic Labs Market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Research Institutes
6.7.1. Research Institutes Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Blood Cancer Diagnostics Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/Reimbursement
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/Reimbursement
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/Reimbursement
7.5.3.3. Competitive scenario
7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/Reimbursement
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/Reimbursement
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/Reimbursement
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/Reimbursement
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/Reimbursement
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/Reimbursement
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/Reimbursement
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/Reimbursement
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/Reimbursement
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/Reimbursement
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/Reimbursement
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/Reimbursement
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/Reimbursement
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/Reimbursement
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/Reimbursement
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/Reimbursement
7.8.2.3. Competitive scenario
7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/Reimbursement
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/Reimbursement
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/Reimbursement
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Illumina
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Services benchmarking
8.3.4.4. Strategic initiatives
8.3.5. InVivoScribe
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Services benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Ipsogen (Qiagen)
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Services benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Asuragen(Bio-Techne)
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Services benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Danaher Corporation
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Services benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Abbott
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Services benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Sequenta (Adaptive biotechnologies)
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Services benchmarking
8.3.10.4. Strategic initiatives
8.3.11. SkylineDx
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Services benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Bio-Rad Laboratories
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Services benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Alercell
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Services benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Sophia Genetics
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Services benchmarking
8.3.14.4. Strategic initiatives

List of Tables
Table 1 List of abbreviations
Table 2 North America blood cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 3 North America blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 4 North America blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 5 North America blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 6 U.S. blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 8 U.S. blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 9 Canada blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 10 Canada blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 11 Canada blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 12 Mexico blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 13 Mexico blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 14 Mexico blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 15 Europe blood cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 16 Europe blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 17 Europe blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 18 Europe blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 19 Germany blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 20 Germany blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 21 Germany blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 22 UK blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 23 UK blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 24 UK blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 25 France blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 26 France blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 27 France blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 28 Italy blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 29 Italy blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 30 Italy blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 31 Spain blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 32 Spain blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 33 Spain blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 34 Denmark blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 35 Denmark blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 36 Denmark blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 Sweden blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 38 Sweden blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 39 Sweden blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 40 Norway blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 41 Norway blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 42 Norway blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific blood cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 44 Asia Pacific blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 45 Asia Pacific blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 46 Asia Pacific blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 47 China blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 48 China blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 49 China blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 50 Japan blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 51 Japan blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 52 Japan blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 53 India blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 54 India blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 55 India blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 56 South Korea blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 57 South Korea blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 58 South Korea blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 59 Australia blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 60 Australia blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 61 Australia blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 62 Thailand blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 63 Thailand blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 64 Thailand blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 65 Latin America blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 66 Latin America blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 67 Latin America blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 68 Brazil blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 69 Brazil blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 70 Brazil blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 71 Argentina blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 72 Argentina blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 73 Argentina blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 74 MEA blood cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 75 MEA blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 76 MEA blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 77 MEA blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 78 South Africa blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 79 South Africa blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 80 South Africa blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 84 UAE blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 85 UAE blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 86 UAE blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 87 Kuwait blood cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 88 Kuwait blood cancer diagnostics market, by test, 2018 - 2030 (USD Million)
Table 89 Kuwait blood cancer diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Blood cancer diagnostics market: market outlook
Fig. 14 Blood cancer diagnostics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Blood cancer diagnostics market driver impact
Fig. 20 Blood cancer diagnostics market restraint impact
Fig. 21 Blood cancer diagnostics market strategic initiatives analysis
Fig. 22 Blood cancer diagnostics market: Product movement analysis
Fig. 23 Blood cancer diagnostics market: Product outlook and key takeaways
Fig. 24 Instruments estimates and forecast, 2018 - 2030
Fig. 25 Assay kits and reagents market estimates and forecast, 2018 - 2030
Fig. 26 Blood cancer diagnostics Market: Test movement analysis
Fig. 27 Blood cancer diagnostics market: Test outlook and key takeaways
Fig. 28 Blood tests market estimates and forecasts, 2018 - 2030
Fig. 29 Imaging tests market estimates and forecasts,2018 - 2030
Fig. 30 Biopsy market estimates and forecasts,2018 - 2030
Fig. 31 Molecular tests market estimates and forecasts,2018 - 2030
Fig. 32 Blood cancer diagnostics market: end use movement analysis
Fig. 33 Blood cancer diagnostics market: end use outlook and key takeaways
Fig. 34 Hospitals and clinics market estimates and forecasts, 2018 - 2030
Fig. 35 Diagnostic labs market estimates and forecasts,2018 - 2030
Fig. 36 Research institutes market estimates and forecasts, 2018 - 2030
Fig. 37 Global blood cancer diagnostics market: Regional movement analysis
Fig. 38 Global blood cancer diagnostics market: Regional outlook and key takeaways
Fig. 39 Global blood cancer diagnostics market share and leading players
Fig. 40 North America market share and leading players
Fig. 41 Europe market share and leading players
Fig. 42 Asia Pacific market share and leading players
Fig. 43 Latin America market share and leading players
Fig. 44 Middle East & Africa market share and leading players
Fig. 45 North America, by country
Fig. 46 North America
Fig. 47 North America market estimates and forecasts, 2018 - 2030
Fig. 48 U.S. key country dynamics
Fig. 49 U.S. market estimates and forecasts, 2018 - 2030
Fig. 50 Canada country dynamics
Fig. 51 Canada market estimates and forecasts, 2018 - 2030
Fig. 52 Mexico country dynamics
Fig. 53 Mexico market estimates and forecasts, 2018 - 2030
Fig. 54 Europe
Fig. 55 Europe market estimates and forecasts, 2018 - 2030
Fig. 56 UK country dynamics
Fig. 57 UK market estimates and forecasts, 2018 - 2030
Fig. 58 Germany
Fig. 59 Germany market estimates and forecasts, 2018 - 2030
Fig. 60 France country dynamics
Fig. 61 France market estimates and forecasts, 2018 - 2030
Fig. 62 Italy country dynamics
Fig. 63 Italy market estimates and forecasts, 2018 - 2030
Fig. 64 Spain country dynamics
Fig. 65 Spain market estimates and forecasts, 2018 - 2030
Fig. 66 Denmark country dynamics
Fig. 67 Denmark market estimates and forecasts, 2018 - 2030
Fig. 68 Sweden country dynamics
Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
Fig. 70 Norway country dynamics
Fig. 71 Norway market estimates and forecasts, 2018 - 2030
Fig. 72 Asia Pacific
Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 74 China country dynamics
Fig. 75 China market estimates and forecasts, 2018 - 2030
Fig. 76 Japan country dynamics
Fig. 77 Japan market estimates and forecasts, 2018 - 2030
Fig. 78 India country dynamics
Fig. 79 India market estimates and forecasts, 2018 - 2030
Fig. 80 Thailand country dynamics
Fig. 81 Thailand market estimates and forecasts, 2018 - 2030
Fig. 82 South Korea country dynamics
Fig. 83 South Korea market estimates and forecasts, 2018 - 2030
Fig. 84 Australia country dynamics
Fig. 85 Australia market estimates and forecasts, 2018 - 2030
Fig. 86 Latin America
Fig. 87 Latin America market estimates and forecasts, 2018 - 2030
Fig. 88 Brazil country dynamics
Fig. 89 Brazil market estimates and forecasts, 2018 - 2030
Fig. 90 Argentina country dynamics
Fig. 91 Argentina market estimates and forecasts, 2018 - 2030
Fig. 92 Middle East and Africa
Fig. 93 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 94 South Africa country dynamics
Fig. 95 South Africa market estimates and forecasts, 2018 - 2030
Fig. 96 Saudi Arabia country dynamics
Fig. 97 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 98 UAE country dynamics
Fig. 99 UAE market estimates and forecasts, 2018 - 2030
Fig. 100 Kuwait country dynamics
Fig. 101 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 102 Market share of key market players- Blood cancer diagnostics market, 2023
Fig. 103 Company Categorization